CLB
Core Laboratories NV
10.90$
+0.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 80.2% | 79.2% | 83.6% | 81.7% | 82.2% | 85.0% | 83.5% | 82.5% | 80.7% | 81.9% | 83.8% | 81.4% | 81.9% | |
| 19.8% | 20.8% | 16.4% | 18.3% | 17.8% | 15.0% | 16.5% | 17.5% | 19.3% | 18.1% | 16.2% | 18.6% | 18.1% | |
| 7.5% | 6.8% | 8.9% | 7.9% | 6.2% | 7.0% | 11.0% | 8.0% | 7.9% | 6.8% | 12.1% | 8.8% | 8.8% | |
| 8.1% | 9.4% | 9.7% | 6.0% | 3.1% | 4.0% | 12.9% | 5.8% | 3.8% | 6.5% | 14.6% | 11.3% | 8.9% | |
| 11.7% | 11.4% | 6.6% | 12.3% | 14.7% | 11.0% | 3.6% | 11.7% | 15.6% | 11.6% | 1.5% | 7.3% | 9.3% | |
| 2.5% | 2.8% | 2.6% | 2.5% | 2.3% | 2.0% | 2.1% | 2.1% | 2.0% | 1.9% | 2.4% | 2.3% | 2.1% | |
| 9.2% | 8.6% | 4.0% | 9.8% | 12.4% | 8.9% | 1.5% | 9.7% | 13.6% | 9.6% | -0.8% | 5.1% | 7.1% | |
| 1.8% | 6.7% | 1.3% | 2.8% | 3.5% | 3.2% | 1.4% | 1.5% | 2.8% | 5.9% | -0.2% | 0.4% | 2.3% | |
| 7.4% | 1.7% | 2.5% | 6.9% | 8.7% | 5.7% | -0.1% | 8.2% | 10.6% | 3.6% | -0.6% | 4.8% | 4.7% | |
| 14.8% | 14.6% | 9.6% | 15.1% | 17.5% | 13.8% | 6.6% | 17.4% | 18.2% | 14.1% | 4.6% | 10.4% | 12.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.